Full video transcriptClick to expand
Auto-generated transcript of @dr.meganlee's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Testosterone replacement for women does not have to be expensive.
- 0:03I have had patients tell me that some compounded testosterone that they've gotten is 60, 70, 80 dollars for a cream.
- 0:09And that's what I was using before, because that was how I could get accurate smaller dosing,
- 0:16because I've seen patients with very, you know, very sensitivity, a lot of sensitivities to just even the slightest increase of those lower doses.
- 0:24And there's not a commercially available testosterone product at CVS.
- 0:28So, or whatever pharmacy.
- 0:31So what my OB shared with me, so thank you for watching this.
- 0:34She does as she puts, takes that test in gel, and I'll use that 1% test in male testosterone, you know, the FDA approved version for men.
- 0:44And they'll do like a pea sized amount.
- 0:47And I will have someone on that who are on about 2.5 or 3.5 milligrams a day, because that pea sized amount comes out to about 2.5 milligrams or 3 milligrams.
- 0:57Judging the saying it's a quarter of an ML, she gets an oral syringe, a 1ML syringe, and puts the testosterone in there.
- 1:04And then you can dose out 0.1MLs, which would be 1 milligram.
- 1:07So that brings your cost down almost 10 fold, because, you know, you can get a 90 day supply, one of those, you know, testosterone 1% gel packs or packets or tubes for $7, $10.
- 1:21So I hope this is helpful for any clinicians out there.
- 1:24If you're doing testosterone replacement therapy, it does not have to hold on to the therapy.
- 1:28It does not have to be expensive.
- 1:29Some insurance people cover it with testosterone, run that FDA approved, so we've got to be a little creative.
- 1:33But I'm going to start switching more patients over this for cost saving purposes, so I hope that's helpful.
DIY topical testosterone for menopause: what the science says
Quick answer
The creator is describing off-label use of FDA-approved male testosterone 1% gel in women, portioned via oral syringe to approximate low-dose ranges consistent with female testosterone therapy guidelines. While off-label use of male testosterone formulations in women is a recognized clinical practice, dosing by volumetric estimate rather than serum monitoring introduces meaningful variability in a population she herself notes can be highly sensitive to small dose changes. Clinicians considering this approach should pair it with baseline and follow-up free and total testosterone levels per the 2019 Global Consensus recommendations.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For DIY topical testosterone for menopause: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
DIY topical testosterone for menopause: what the science says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "DIY topical testosterone for menopause: what the science says" from Dr Megan | Menopause Care. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is describing off-label use of FDA-approved male testosterone 1% gel in women, portioned via oral syringe to approximate low-dose ranges consistent with female testosterone therapy guidelines.
The reason this review is not generic is the source wording and the canonical claim label "trt hormone replacement therapy does not have to be expensive he." In this clip, the useful excerpt is: "Testosterone replacement for women does not have to be expensive." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator is describing off-label use of FDA-approved male testosterone 1% gel in women, portioned via oral syringe to approximate low-dose ranges consistent with female testosterone therapy guidelines.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is describing off-label use of FDA-approved male testosterone 1% gel in women, portioned via oral syringe to approximate low-dose ranges consistent with female testosterone therapy guidelines. While off-label use of male testosterone formulations in women is a recognized clinical practice, dosing by volumetric estimate rather than serum monitoring introduces meaningful variability in a population she herself notes can be highly sensitive to small dose changes. Clinicians considering this approach should pair it with baseline and follow-up free and total testosterone levels per the 2019 Global Consensus recommendations.
- No FDA-approved testosterone product exists for women in the U.S. as of 2024, confirmed by the 2019 Global Consensus Position Statement in the Journal of Clinical Endocrinology and Metabolism.
- Off-label use of male testosterone formulations in women is a recognized clinical practice, but it requires serum testosterone monitoring before and during treatment, not volume-based dosing estimates alone.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- No FDA-approved testosterone product exists for women in the U.S. as of 2024, confirmed by the 2019 Global Consensus Position Statement in the Journal of Clinical Endocrinology and Metabolism.
- Off-label use of male testosterone formulations in women is a recognized clinical practice, but it requires serum testosterone monitoring before and during treatment, not volume-based dosing estimates alone.
- A 2019 Islam et al. study in JAMA Internal Medicine found that supraphysiologic testosterone in women is associated with irreversible androgenic effects including voice changes and clitoral enlargement, making dosing precision especially important.
- Generic testosterone 1% gel costs significantly less than compounded creams through discount programs, and the cost argument made in this video is legitimate and worth patients discussing with their providers.
- Davis et al. (2015, Climacteric) documented that testosterone absorption from topical gels varies substantially by application site, skin thickness, and individual metabolism, which limits the reliability of volume-based dose estimates.
- Patients with self-described hormone sensitivity, as the creator mentions, are precisely the population that needs tighter monitoring protocols, not looser delivery methods.
- Insurance coverage of FDA-approved testosterone used off-label for women is variable and not guaranteed, so patients should verify coverage before assuming this approach will be affordable.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @dr.meganlee actually say?
She proposed that clinicians skip expensive compounded testosterone creams (she cited prices of "60, 70, 80 dollars") and instead use FDA-approved 1% testosterone gel designed for men, measured into an oral syringe to deliver smaller doses. Her claim is that a pea-sized amount equals roughly 2.5 to 3 milligrams, and that a 90-day supply can cost as little as "$7 to $10." She framed this as a cost-saving workaround for women who need low-dose testosterone but lack access to affordable compounded products or a commercially available women's formulation.
She also noted that some insurance covers FDA-approved testosterone products, which she positioned as an advantage over compounded alternatives that are almost never covered.
Does the science back this up?
The underlying rationale, that women can benefit from low-dose testosterone therapy, has real support in the literature. But the delivery hack she describes introduces meaningful dosing uncertainty that the science on women's testosterone therapy makes hard to ignore.
A 2019 global consensus position statement published in The Journal of Clinical Endocrinology and Metabolism (Baber et al., 2019) confirmed that testosterone therapy in women has evidence for treating hypoactive sexual desire disorder, but explicitly noted that no product is currently approved for women in the U.S. and that dosing precision matters considerably. Women typically need 1/10th to 1/20th the male dose. Using a male-formulated gel and estimating dose by "a pea-sized amount" and oral syringe measurement is not a validated method. Gel concentration can vary by application site, skin thickness, and individual absorption rates (Davis et al., 2015, Climacteric). The cost argument is sound. The precision argument is shakier.
What did they get wrong (or right)?
Credit where it is due: she is right that compounded testosterone for women is expensive and inconsistently covered by insurance, and she is right that there is no FDA-approved testosterone product for women in the U.S. pharmacy system. Those are real problems that real patients face every day.
Where she runs into trouble is the dosing confidence. Saying "a pea-sized amount comes out to about 2.5 or 3 milligrams" treats a rough volumetric estimate as clinical precision. It is not. Gel viscosity, tube-to-tube variability, and the fact that she herself acknowledged patients can have sensitivity to "even the slightest increase" make this combination risky. Testosterone gel for men is also typically applied to the shoulders or upper arms, and absorption in those areas is calibrated for male skin physiology. Women applying the same gel to different sites may absorb more or less than expected.
She also said she will "start switching more patients over" to this method, which is a significant clinical decision announced on TikTok without acknowledging the need for careful monitoring or baseline labs. That framing deserves scrutiny.
What should you actually know?
If you are a patient considering this approach, do not attempt it without a prescribing clinician who can monitor serum testosterone levels. The Global Consensus Statement (Baber et al., 2019) recommends measuring free and total testosterone before and during therapy, with dose adjustments based on bloodwork, not syringe estimates. Supraphysiologic testosterone in women, even slightly elevated, is associated with acne, hair loss, clitoral enlargement, and voice changes, some of which are irreversible (Islam et al., 2019, JAMA Internal Medicine).
The cost argument is genuinely valid and worth advocating for. The method she describes is not inherently wrong in concept, but "creative" workarounds with hormones require tighter clinical guardrails than a TikTok video can reasonably convey. Patients should ask their provider specifically about monitoring protocols, not just the prescription.
- No FDA-approved testosterone product exists for women in the U.S. as of 2024.
- Compounded testosterone is legal but not FDA-reviewed for consistency or potency.
- Using male-formulated gel off-label for women is a common clinical practice, but dosing by volume estimate alone is not a validated method.
- Insurance coverage of FDA-approved testosterone (male formulations, used off-label) is variable and not guaranteed.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr Megan | Menopause Care · TikTok creator
16.5K views on this video
Hormone replacement therapy does not have to be expensive. Here’s a way to make topical testosterone even more accessible. #hormonereplacementtherapy #testosterone #menopause #perimenopause
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about no fda-approved testosterone product exists for women in the u.s.?
No FDA-approved testosterone product exists for women in the U.S. as of 2024, confirmed by the 2019 Global Consensus Position Statement in the Journal of Clinical Endocrinology and Metabolism.
What does the video say about off-label use of male testosterone formulations in women?
Off-label use of male testosterone formulations in women is a recognized clinical practice, but it requires serum testosterone monitoring before and during treatment, not volume-based dosing estimates alone.
What does the video say about a 2019 islam et al. study in jama internal medicine?
A 2019 Islam et al. study in JAMA Internal Medicine found that supraphysiologic testosterone in women is associated with irreversible androgenic effects including voice changes and clitoral enlargement, making dosing precision especially important.
What does the video say about generic testosterone 1% gel costs significantly less than compounded creams?
Generic testosterone 1% gel costs significantly less than compounded creams through discount programs, and the cost argument made in this video is legitimate and worth patients discussing with their providers.
What does the video say about davis et al. (2015, climacteric) documented?
Davis et al. (2015, Climacteric) documented that testosterone absorption from topical gels varies substantially by application site, skin thickness, and individual metabolism, which limits the reliability of volume-based dose estimates.
What does the video say about patients with self-described hormone sensitivity, as the creator mentions,?
Patients with self-described hormone sensitivity, as the creator mentions, are precisely the population that needs tighter monitoring protocols, not looser delivery methods.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr Megan | Menopause Care, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.